Merck & Co., Inc.

MRK.MX·Mexico·Healthcare
Compare
2,800.00+70.00 (+2.56%)today
At close: Oct 21, 1:58 PM CST · May be delayed up to 20 min · MXN

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,730.00
Open2,750.01
Day range2,750.012,800.00
52-week range1,531.002,800.00
Off day high0.00%
Off 52-week high0.00%
Volume20.00
Avg. volume (3M)2.18K
Market cap6.91T
EPS (TTM)22.67
Forward P/E—
P/E ratio (TTM)123.51
Dividend yield2.18% (61.11)
Beta (5Y)0.22
Shares outstanding2.47B
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin4.77%

Against its peers

Compare in full ›
MRK.MX 4578.T AZN PFE JNJ JNJ.NE
Market cap 6.91T 6.50T 264.80B 171.50B 629.75B 849.61B
P/E (TTM) 123.5 16.3 25.5 39.6 39.7 23.5
Forward P/E — 23.9 15.1 10.4 22.5 —
Price/book 8.9 2.0 5.3 2.0 7.4 0.7
Dividend yield 2.18% 1.60% 1.90% 5.76% 2.08% 2.49%
1-year change +75.04% +50.31% +0.99% +21.00% +33.93% +40.84%
Today +2.56% −0.84% +1.37% +0.77% +1.42% 0.00%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Merck's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Otsuka Holdings Co., Ltd.4578.T · Drug Manufacturers - General 6.50T 12,395.00 −0.84%
AstraZeneca PLCAZN · Drug Manufacturers - General 264.80B 170.74 +1.37%
Pfizer Inc.PFE · Drug Manufacturers - GeneralOdds 171.50B 30.09 +0.77%
Johnson & JohnsonJNJ · Drug Manufacturers - General 629.75B 261.32 +1.42%
JOHNSON & JOHNSON CDR (CAD HEDGJNJ.NE · Drug Manufacturers - General 849.61B 32.73 0.00%
Eli Lilly and CompanyLLY · Drug Manufacturers - GeneralOdds 1.15T 1,290.55 +1.44%
Novartis AGNVS · Drug Manufacturers - General 295.09B 155.25 +0.85%
GSK plcGSK · Drug Manufacturers - General 100.84B 50.33 +0.54%

Other companies in Drug Manufacturers - General, closest in size first.

Company Mkt cap Price Today
Otsuka Holdings Co., Ltd.4578.T · Chiyoda, Japan 6.50T 12,395.00 −0.84%
Daiichi Sankyo Company, Limited4568.T · Chuo, Japan 5.16T 2,836.50 −0.16%
Astellas Pharma Inc.4503.T · Chuo, Japan 4.46T 2,487.50 −0.12%
Chugai Pharmaceutical Co., Ltd.4519.T · Chuo, Japan 10.88T 6,614.00 +1.58%
Amgen Inc.AMGN.MX · Thousand Oaks, CA 4.05T 7,500.01 0.00%
Gilead Sciences, Inc.GILD.MX · Foster City, CA 3.56T 2,869.25 0.00%
Novo Nordisk A/SNVON.MX · Bagsvaerd, Denmark 3.23T 731.99 +0.97%
Pfizer Inc.PFE.MX · New York, NY 3.17T 555.34 −0.21%

The stocks whose daily moves over the past year went most closely with Merck's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Pfizer Inc.PFE.MX · Correlation 0.37 3.17T 555.34 −0.21%
Johnson & JohnsonJNJ.MX · Correlation 0.33 11.56T 4,797.00 +0.57%
The Coca-Cola CompanyKO.MX · Correlation 0.31 7.45T 1,731.00 +0.69%

What visitors to Merck's page also look at.

Company Mkt cap Price Today
PFIZER INCPFE.MX 3.17T 555.34 −0.21%
JOHNSON & JOHNSONJNJ.MX 11.56T 4,797.00 +0.57%
PROCTER & GAMBLE COPG.MX 6.81T 2,931.00 +0.07%
VISA INCV.MX 14.26T 7,596.00 +1.42%
COCA-COLA COKO.MX 7.45T 1,731.00 +0.69%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All MRK.MX news ›
pharmaphorum·

Merck buys Silence and its siRNA pipeline for $1.3bn

Merck KGaA has reached a deal to acquire UK-based Silence Therapeutics in ​an all-cash, $1.3 billion deal that will boost its presence in RNA-focused drugs and give it a late-stage drug candidate for rare disease polycythemia vera (PV).…

Seeking Alpha·Positive

Merck KGaA to buy Silence Therapeutics in all-cash deal

Merck KGaA to acquire Silence Therapeutics for $1.3B cash, a 130% premium, boosting siRNA pipeline and rare-disease focus. Merck KGaA (MKGAY) (MKGAF) has agreed to acquire Silence Therapeutics (SLN) in an all-cash deal with an enterprise…

medwatch.com·

Merck buys biotech Silence Therapeutics for USD 1.1bn

Senior Drug Product Filling Specialist Associate Market Access Director – International Markets Senior Drug Substance Scientist Head of Medical Affairs International Markets Chef for Kvalitet og Compliance Head of Clinical Operations…

TIKR.com·Positive

Better Dividend Stock: Merck vs. Bristol Myers Squibb

Pressmaster from Pressmaster and Ri_Ya from pixabay Merck (MRK) and Bristol Myers Squibb (BMY) both raised their 2026 sales outlooks this summer. That’s good news for income investors, since a growing business keeps a dividend growing. The…

From articles in the 4Search news index.

In the news

278mentions in 30 days
193with it in the headline
Positivesentiment

Mentioned with

Merck & Co., Inc.228Pfizer201Merck Kgaa134Johnson & Johnson133Morgan Stanley114Life Sciences Innovation112Eli Lilly and Company105Merck & CO104

People in the coverage

Keytruda176Moderna139Sarita Garza114Kim Johansen106Basaglar103Mitch Edgeman102

Themes

Pharmaceuticals134Healthcare114Equities110Lly93Jnj84Biotechnology80Pharma74Merck Kgaa59

Most coverage from

  1. marketscreener.com59
  2. marketbeat.com25
  3. tradingview.com12
  4. themarketsdaily.com11
  5. defenseworld.net10

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.